Literature DB >> 25590559

Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.

Hongbo Ling1, Kazuhiko Hanashiro, Tran H Luong, Luis Benavides, Kenji Fukasawa.   

Abstract

The presence of more than 2 centrosomes (centrosome amplification) leads to defective mitosis and chromosome segregation errors, is frequently found in a variety of cancer types, and believed to be the major cause of chromosome instability. One mechanism for generation of amplified centrosomes is over-duplication of centrosomes in a single cell cycle, which is expected to occur when cells are temporarily arrested. There are a growing number of kinases that are critical for induction and promotion of centrosome amplification in the cell cycle-arrested cells, including Rho-associated kinase (ROCK2), Polo-like kinase 2 (PLK2) and PLK4. Here, we tested whether these kinases induce centrosome amplification in a linear pathway or parallel pathways. We first confirmed that ROCK2, PLK2 and PLK4 are all essential for centrosomes to re-duplicate in the cells arrested by exposure to DNA synthesis inhibitor. Using the centrosome amplification rescue assay, we found that PLK2 indirectly activates ROCK2 via phosphorylating nucleophosmin (NPM), and PLK4 functions downstream of ROCK2 to drive centrosome amplification in the arrested cells.

Entities:  

Keywords:  Aph, aphidicolin; B23; CDK2, Cyclin-dependent kinase 2; DN, dominant-negative; KD, kinase-dead; MEFs, mouse embryonic fibroblasts; NPM; NPM, Nucleophosmin; PLK2; PLK2, Polo-like kinase 2; PLK4; PLK4, Polo-like kinase 4; Puro, puromycin; ROCK2; ROCK2, Rho-(associated) kinase; centrosome; nucleophosmin; polo-like kinase; wt, wild type

Mesh:

Substances:

Year:  2015        PMID: 25590559      PMCID: PMC4614521          DOI: 10.4161/15384101.2014.989121

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  33 in total

1.  Nucleolar protein B23 has molecular chaperone activities.

Authors:  A Szebeni; M O Olson
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.

Authors:  Y Matsumoto; K Hayashi; E Nishida
Journal:  Curr Biol       Date:  1999-04-22       Impact factor: 10.834

3.  Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts.

Authors:  E H Hinchcliffe; C Li; E A Thompson; J L Maller; G Sluder
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

4.  Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis.

Authors:  H Goto; H Kosako; K Tanabe; M Yanagida; M Sakurai; M Amano; K Kaibuchi; M Inagaki
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

5.  Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication.

Authors:  Zhiyong Ma; Masayuki Kanai; Kenji Kawamura; Kozo Kaibuchi; Keqiang Ye; Kenji Fukasawa
Journal:  Mol Cell Biol       Date:  2006-10-02       Impact factor: 4.272

Review 6.  Centrosome amplification, chromosome instability and cancer development.

Authors:  Kenji Fukasawa
Journal:  Cancer Lett       Date:  2005-12-08       Impact factor: 8.679

7.  The Polo kinase Plk4 functions in centriole duplication.

Authors:  Robert Habedanck; York-Dieter Stierhof; Christopher J Wilkinson; Erich A Nigg
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

8.  Cyclin-dependent kinase control of centrosome duplication.

Authors:  K R Lacey; P K Jackson; T Stearns
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Plk4-induced centriole biogenesis in human cells.

Authors:  Julia Kleylein-Sohn; Jens Westendorf; Mikael Le Clech; Robert Habedanck; York-Dieter Stierhof; Erich A Nigg
Journal:  Dev Cell       Date:  2007-08       Impact factor: 12.270

10.  SAK/PLK4 is required for centriole duplication and flagella development.

Authors:  M Bettencourt-Dias; A Rodrigues-Martins; L Carpenter; M Riparbelli; L Lehmann; M K Gatt; N Carmo; F Balloux; G Callaini; D M Glover
Journal:  Curr Biol       Date:  2005-12-01       Impact factor: 10.834

View more
  7 in total

1.  Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication.

Authors:  Hongbo Ling; Lirong Peng; Jianbo Wang; Raneen Rahhal; Edward Seto
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

2.  Cytoplasmic nucleophosmin has elevated T199 phosphorylation upon which G2/M phase progression is dependent.

Authors:  Narisa Chan; Tit Meng Lim
Journal:  Sci Rep       Date:  2015-06-30       Impact factor: 4.379

3.  RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.

Authors:  Annapurna Pranatharthi; Pavana Thomas; Avinash H Udayashankar; Chandra Bhavani; Srinag Bangalore Suresh; Sudhir Krishna; Jayashree Thatte; Nirmala Srikantia; Cecil R Ross; Sweta Srivastava
Journal:  J Exp Clin Cancer Res       Date:  2019-09-05

Review 4.  Polo-Like Kinase 2: From Principle to Practice.

Authors:  Chuanyong Zhang; Chuangye Ni; Hao Lu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

5.  14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression.

Authors:  Amitabha Mukhopadhyay; Lalit Sehgal; Arunabha Bose; Anushree Gulvady; Parijat Senapati; Rahul Thorat; Srikanta Basu; Khyati Bhatt; Amol S Hosing; Renu Balyan; Lalit Borde; Tapas K Kundu; Sorab N Dalal
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

6.  High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer.

Authors:  Yao He; Hui Wang; Meina Yan; Xinxin Yang; Rong Shen; Xiaoge Ni; Xiaokun Chen; Peifang Yang; Miao Chen; Xiaodong Lu; Genbao Shao; Xiaoming Zhou; Qixiang Shao
Journal:  Mol Med Rep       Date:  2018-10-16       Impact factor: 2.952

7.  Biological and clinical significance of flap endonuclease‑1 in triple‑negative breast cancer: Support of metastasis and a poor prognosis.

Authors:  Lu Xu; Jing-Lei Qu; Na Song; Ling-Yun Zhang; Xue Zeng; Xiao-Fang Che; Ke-Zuo Hou; Sha Shi; Zu-Ying Feng; Xiu-Juan Qu; Yun-Peng Liu; Yue-E Teng
Journal:  Oncol Rep       Date:  2020-10-16       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.